ADMS
Adamas Pharmaceuticals
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
98 hedge funds and large institutions have $150M invested in Adamas Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 30 increasing their positions, 30 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
19% less call options, than puts
Call options by funds: $637K | Put options by funds: $786K
27% less capital invested
Capital invested by funds: $207M → $150M (-$56.6M)
Holders
98
Holding in Top 10
3
Calls
$637K
Puts
$786K
Top Buyers
| 1 | +$14.8M | |
| 2 | +$7M | |
| 3 | +$3.83M | |
| 4 |
DAM
Deltec Asset Management
New York
|
+$2.14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.75M |
Top Sellers
| 1 | -$18M | |
| 2 | -$10.8M | |
| 3 | -$8.37M | |
| 4 |
Morgan Stanley
New York
|
-$3.91M |
| 5 |
Renaissance Technologies
New York
|
-$2.81M |